Clinical Trials Browser

Phase 2 × Dermatofibrosarcoma × Ipilimumab × Clear all

NCT04480502 2024-05-17

ENVASARC

Phase 2 Active not recruiting

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous